Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12035-013-8416-8.

Title:
Glaucoma: An Extension of Various Chronic Neurodegenerative Disorders | Molecular Neurobiology
Description:
The eyes are the window of the brain; various pathologies of the eyes can be explained on the basis of neurological disorders and vice versa. Today, our only approach for the management of glaucoma is intraocular pressure (IOP) reduction, whether by pharmacological or surgical methods. Available methods may effectively control IOP but fall short of stopping the progression of glaucoma. IOP is just one of the risk factors our therapy addresses, so we need to work towards shifting our approach towards addressing other factors involved in the etiopathogenesis of the disease. Pathogenesis of glaucoma at molecular level can be compared with that of common neurodegenerative diseases like Alzheimer’s and Parkinsonism. Targets for therapeutic intervention in chronic neurodegenerative diseases and glaucoma include apoptosis, axonal transport, free radical damage, role of polyunsaturated fatty acids, chaperones, gene regulation, etc. p38MAPK is a common pathway involved in all the neurodegenerative disease and glaucoma as well, and more research in this direction can be really beneficial for the development of novel diagnostic and therapeutic measures.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

google, scholar, article, pubmed, cas, glaucoma, disease, neurodegenerative, alzheimers, ophthalmol, diseases, brain, acid, fatty, vis, sci, patients, parkinsons, privacy, cookies, content, jindal, access, glaucomatous, retinal, amyloid, precursor, protein, salem, publish, research, search, molecular, vishal, polyunsaturated, optic, ocular, mol, curr, activation, ferrari, neurol, mouse, signaling, neurochem, kinase, calon, docosahexaenoic, dietary, function,

Topics {✒️}

month download article/chapter stress-activated map kinase toxin-induced neuronal degeneration optic nerve head rat ocular hypertension glaucomatous optic neuropathy staurosporine-induced apoptosis quigley ha chronic neurodegenerative diseases common neurodegenerative diseases normal-tension glaucoma polyunsaturated fatty acids glaucoma include apoptosis open-angle glaucoma full article pdf omega-3 fatty acids retinal diseases phosphatidylinositol-3 kinase pathway map kinase pathways amyloid precursor protein amyloid precursor protein privacy choices/manage cookies mckinnon sj neurodegenerative diseases glaucomatous neurodegeneration retinal tau pathology chronic neurodegenerative disorders related subjects reduced retinal function transgenic mouse model calcineurin/nfat signaling article jindal docosahexaenoic acid protects european economic area free radical damage apoptotic cell death cortical motor neurons early presymptomatic stages amyotrophic lateral sclerosis manning-bog ab decreases nmda receptors targeting amyloid-β amyloid-β immunoreactivity conditions privacy policy kerrigan-baumrind la common pathway involved high occurrence rate vitreous fluid levels increased tau levels decreased β-amyloid1–42

Questions {❓}

  • Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Glaucoma: An Extension of Various Chronic Neurodegenerative Disorders
         description:The eyes are the window of the brain; various pathologies of the eyes can be explained on the basis of neurological disorders and vice versa. Today, our only approach for the management of glaucoma is intraocular pressure (IOP) reduction, whether by pharmacological or surgical methods. Available methods may effectively control IOP but fall short of stopping the progression of glaucoma. IOP is just one of the risk factors our therapy addresses, so we need to work towards shifting our approach towards addressing other factors involved in the etiopathogenesis of the disease. Pathogenesis of glaucoma at molecular level can be compared with that of common neurodegenerative diseases like Alzheimer’s and Parkinsonism. Targets for therapeutic intervention in chronic neurodegenerative diseases and glaucoma include apoptosis, axonal transport, free radical damage, role of polyunsaturated fatty acids, chaperones, gene regulation, etc. p38MAPK is a common pathway involved in all the neurodegenerative disease and glaucoma as well, and more research in this direction can be really beneficial for the development of novel diagnostic and therapeutic measures.
         datePublished:2013-02-10T00:00:00Z
         dateModified:2013-02-10T00:00:00Z
         pageStart:186
         pageEnd:189
         sameAs:https://doi.org/10.1007/s12035-013-8416-8
         keywords:
            Glaucoma
            Ganglion cells
            Parkinsonism
            Alzheimer’s disease
            Neurosciences
            Neurobiology
            Cell Biology
            Neurology
         image:
         isPartOf:
            name:Molecular Neurobiology
            issn:
               1559-1182
               0893-7648
            volumeNumber:48
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Vishal Jindal
               affiliation:
                     name:Government Medical College and Hospital
                     address:
                        name:Government Medical College and Hospital, Chandigarh, India
                        type:PostalAddress
                     type:Organization
                     name:
                     address:
                        name:Panchkula, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Glaucoma: An Extension of Various Chronic Neurodegenerative Disorders
      description:The eyes are the window of the brain; various pathologies of the eyes can be explained on the basis of neurological disorders and vice versa. Today, our only approach for the management of glaucoma is intraocular pressure (IOP) reduction, whether by pharmacological or surgical methods. Available methods may effectively control IOP but fall short of stopping the progression of glaucoma. IOP is just one of the risk factors our therapy addresses, so we need to work towards shifting our approach towards addressing other factors involved in the etiopathogenesis of the disease. Pathogenesis of glaucoma at molecular level can be compared with that of common neurodegenerative diseases like Alzheimer’s and Parkinsonism. Targets for therapeutic intervention in chronic neurodegenerative diseases and glaucoma include apoptosis, axonal transport, free radical damage, role of polyunsaturated fatty acids, chaperones, gene regulation, etc. p38MAPK is a common pathway involved in all the neurodegenerative disease and glaucoma as well, and more research in this direction can be really beneficial for the development of novel diagnostic and therapeutic measures.
      datePublished:2013-02-10T00:00:00Z
      dateModified:2013-02-10T00:00:00Z
      pageStart:186
      pageEnd:189
      sameAs:https://doi.org/10.1007/s12035-013-8416-8
      keywords:
         Glaucoma
         Ganglion cells
         Parkinsonism
         Alzheimer’s disease
         Neurosciences
         Neurobiology
         Cell Biology
         Neurology
      image:
      isPartOf:
         name:Molecular Neurobiology
         issn:
            1559-1182
            0893-7648
         volumeNumber:48
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Vishal Jindal
            affiliation:
                  name:Government Medical College and Hospital
                  address:
                     name:Government Medical College and Hospital, Chandigarh, India
                     type:PostalAddress
                  type:Organization
                  name:
                  address:
                     name:Panchkula, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular Neurobiology
      issn:
         1559-1182
         0893-7648
      volumeNumber:48
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Government Medical College and Hospital
      address:
         name:Government Medical College and Hospital, Chandigarh, India
         type:PostalAddress
      name:
      address:
         name:Panchkula, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Vishal Jindal
      affiliation:
            name:Government Medical College and Hospital
            address:
               name:Government Medical College and Hospital, Chandigarh, India
               type:PostalAddress
            type:Organization
            name:
            address:
               name:Panchkula, India
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Government Medical College and Hospital, Chandigarh, India
      name:Panchkula, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(140)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.96s.